Summary Part 2 The Issuer 2.1 Objectives of the fund 2.2 Business operation 1. Policy and overview of business operation 2. Nature of business operation 3. Risk factors 4. Research and development 5. Assets
for selecting an analysis/a research to support an investment decision. (4) Prescription of criteria in selecting each asset/group of asset to be actively or passively* invested in order to reduce risk
: - Industry analysis: - Study and analysis of fundamental factors of the business to be invested. (3) Prescription of criteria for selecting an analysis/a research to support an investment decision. (4
with growth higher than the Bank in-house research forecasted of 8.0%. The number of new car sales for the first 11 months of 2017 totaled 767,345 units, a growth of 12.5% with the growth for the
showed continuous recovery with growth higher than the Bank in- house research forecasted of 8.0%. The number of new car sales for total year 2017 totaled 871,647 units, a growth of 13.4% with the growth
. Investment in raw material extraction plant and world-class research laboratory 100 100 100 - 2018-2019 2. Development of the Company’s new brand 200 200 200 - 2018-2020 บริษัท ดีโอดี ไบโอเทค จ ำกัด (มหำชน
percent Purposes of use of proceeds disclosed in the registration statement for offer for sale of securities and draft prospectus 1. Investment in raw material extraction plant and world-class research
กัทรัพย ์(Soft Dollar) เช่น การไดรั้บบทวิเคราะห์ (research) จากการใชบ้ริการนายหนา้ซ้ือขายหลกัทรัพย ์ การไดรั้บเชิญใหไ้ปร่วมงานสัมมนาโดยไดรั้บบริการท่ีพกัและอาหารฟรีจากบริษทัผูอ้อกหลกัทรัพย ์ อนัเน่ืองมาจาก
COMPANY LIMITED ASIA FIBER PUBLIC COMPANY LIMITED ASIA GREEN ENERGY PUBLIC COMPANY LIMITED ASIA HOTEL PUBLIC COMPANY LIMITED ASIA MEDICAL AND AGRICULTURAL LABORATORY AND RESEARCH CENTER PUBLIC COMPANY
COMPANY LIMITED ASIA FIBER PUBLIC COMPANY LIMITED ASIA GREEN ENERGY PUBLIC COMPANY LIMITED ASIA HOTEL PUBLIC COMPANY LIMITED ASIA MEDICAL AND AGRICULTURAL LABORATORY AND RESEARCH CENTER PUBLIC COMPANY